Skip to main content
Premium Trial:

Request an Annual Quote

Products & Services: Sep 16, 2010

Premium

Norgen Biotek has launched three new urine concentration, preservation, and isolation kits for preparing DNA, RNA, microRNA, and proteins from less than 1 mL to up to 30 mL of urine for applications such as PCR, RT-PCR, qPCR, qRT-PCR, and microarray analysis.

The kits contain a Urine Concentration and Preservation Device that the company said enables rapid and simple urine concentration without the use of centrifugation, as well as preservation of DNA, RNA, and proteins in urine samples at ambient temperature. The kit also includes a Urine Preservative that prevents the growth of bacteria and fungi and inactivates viruses.

Urine DNA, RNA, and proteins in preserved samples are stable for a year at room temperature, the company said.


Sistemic has launched its SistemQC services, which monitor cells for intended or unintended change.

SistemQC is based on the company's SistemRNA technology, which profiles microRNA expression. The service uses proprietary algorithms to analyze the miRNA dataset that is produced when a cell is perturbed by a stimulus in order to provide a phenotypic "fingerprint" of the cell system.

SistemQC is suitable for use in all cells including BHK, CHO, HEK-293, NS0, PER.C6, and hybridomas, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.